ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
BERGETHON, Kristin, SHAW, Alice T, MARK, Eugene J, BATTEN, Julie M, HAIQUAN CHEN, WILNER, Keith D, KWAK, Eunice L, CLARK, Jeffrey W, CARBONE, David P, HONGBIN JI, ENGELMAN, Jeffrey A, MINO-KENUDSON, Mari, IGNATIUS OU, Sai-Hong, PAO, William, IAFRATE, A. John, KATAYAMA, Ryohei, LOVLY, Christine M, MCDONALD, Nerina T, MASSION, Pierre P, SIWAK-TAPP, Christina, GONZALEZ, Adriana, RONG FANG
Published in Journal of clinical oncology (10.03.2012)
Published in Journal of clinical oncology (10.03.2012)
Get full text
Journal Article
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Bell, Erica Hlavin, Chakraborty, Arup R, Mo, Xiaokui, Liu, Ziyan, Shilo, Konstantin, Kirste, Simon, Stegmaier, Petra, McNulty, Maureen, Karachaliou, Niki, Rosell, Rafael, Bepler, Gerold, Carbone, David P, Chakravarti, Arnab
Published in Clinical cancer research (15.05.2016)
Published in Clinical cancer research (15.05.2016)
Get full text
Journal Article
Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC
Shukuya, Takehito, Ghai, Vikas, Amann, Joseph M., Okimoto, Tamio, Shilo, Konstantin, Kim, Taek-Kyun, Wang, Kai, Carbone, David P.
Published in Journal of thoracic oncology (01.11.2020)
Published in Journal of thoracic oncology (01.11.2020)
Get full text
Journal Article
Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival
Andersen, Barbara L, Myers, John, Blevins, Tessa, Park, Kylie R, Smith, Rachel M, Reisinger, Sarah, Carbone, David P, Presley, Carolyn J, Shields, Peter G, Carson, William E
Published in PloS one (24.02.2023)
Published in PloS one (24.02.2023)
Get full text
Journal Article
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting
Abernethy, Amy P, Arunachalam, Ashwini, Burke, Thomas, McKay, Caroline, Cao, Xiting, Sorg, Rachael, Carbone, David P
Published in PloS one (23.06.2017)
Published in PloS one (23.06.2017)
Get full text
Journal Article
Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
Divan, Hozefa A, Bittoni, Marisa A, Krishna, Ashok, Carbone, David P
Published in BMC cancer (06.04.2024)
Published in BMC cancer (06.04.2024)
Get full text
Journal Article
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial
Neal, Joel W, Dr, Dahlberg, Suzanne E, PhD, Wakelee, Heather A, MD, Aisner, Seena C, Prof, Bowden, Michaela, PhD, Huang, Ying, MD, Carbone, David P, Prof, Gerstner, Gregory J, MD, Lerner, Rachel E, MD, Rubin, Jerome L, MD, Owonikoko, Taofeek K, MD, Stella, Philip J, MD, Steen, Preston D, MD, Khalid, Ahmed Ali, MD, Ramalingam, Suresh S, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016
Tan, Daniel S.W., Yom, Sue S., Tsao, Ming S., Pass, Harvey I., Kelly, Karen, Peled, Nir, Yung, Rex C., Wistuba, Ignacio I., Yatabe, Yasushi, Unger, Michael, Mack, Philip C., Wynes, Murry W., Mitsudomi, Tetsuya, Weder, Walter, Yankelevitz, David, Herbst, Roy S., Gandara, David R., Carbone, David P., Bunn, Paul A., Mok, Tony S.K., Hirsch, Fred R.
Published in Journal of thoracic oncology (01.07.2016)
Published in Journal of thoracic oncology (01.07.2016)
Get full text
Journal Article
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Arasada, Rajeswara Rao, Shilo, Konstantin, Yamada, Tadaaki, Zhang, Jianying, Yano, Seiji, Ghanem, Rashelle, Wang, Walter, Takeuchi, Shinji, Fukuda, Koji, Katakami, Nobuyuki, Tomii, Keisuke, Ogushi, Fumitaka, Nishioka, Yasuhiko, Talabere, Tiffany, Misra, Shrilekha, Duan, Wenrui, Fadda, Paolo, Rahman, Mohammad A., Nana-Sinkam, Patrick, Evans, Jason, Amann, Joseph, Tchekneva, Elena E., Dikov, Mikhail M., Carbone, David P.
Published in Nature communications (10.08.2018)
Published in Nature communications (10.08.2018)
Get full text
Journal Article
Adenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, Sergey V., Ryzhov, Sergey, Zaynagetdinov, Rinat, Goldstein, Anna E., Huang, Yuhui, Tikhomirov, Oleg Y., Blackburn, Michael R., Biaggioni, Italo, Carbone, David P., Feoktistov, Igor, Dikov, Mikhail M.
Published in Blood (01.09.2008)
Published in Blood (01.09.2008)
Get full text
Journal Article
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
Vickers, Adrian D, Winfree, Katherine B, Cuyun Carter, Gebra, Kiiskinen, Urpo, Jen, Min-Hua, Stull, Donald, Kaye, James A, Carbone, David P
Published in BMC cancer (15.04.2019)
Published in BMC cancer (15.04.2019)
Get full text
Journal Article
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Spakowicz, Daniel, Hoyd, Rebecca, Muniak, Mitchell, Husain, Marium, Bassett, James S, Wang, Lei, Tinoco, Gabriel, Patel, Sandip H, Burkart, Jarred, Miah, Abdul, Li, Mingjia, Johns, Andrew, Grogan, Madison, Carbone, David P, Verschraegen, Claire F, Kendra, Kari L, Otterson, Gregory A, Li, Lang, Presley, Carolyn J, Owen, Dwight H
Published in BMC cancer (06.05.2020)
Published in BMC cancer (06.05.2020)
Get full text
Journal Article
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib
Zhao, Jun, Lin, Gen, Zhuo, Minglei, Fan, Zaiwen, Miao, Liyun, Chen, Likun, Zeng, Aiping, Yin, Rong, Ou, Yangming, Shi, Zhihui, Yin, Jie, Gao, Wen, Chen, Jianhua, Zhou, Xiangdong, Zeng, Yong, Liu, Xiang, Xu, Huamin, Chen, Rongrong, Xia, Xuefeng, Carbone, David P.
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2020)
Get full text
Journal Article
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Hu, Huabin, She, Longjiang, Liao, Mengting, Shi, Yin, Yao, Linli, Ding, Dong, Zhu, Youwen, Zeng, Shan, Carbone, David P., Huang, Jin
Published in Frontiers in oncology (08.09.2020)
Published in Frontiers in oncology (08.09.2020)
Get full text
Journal Article
Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients
Zhou, Zhen, Ding, Zhengping, Yuan, Jie, Shen, Shengping, Jian, Hong, Tan, Qiang, Yang, Yunhai, Chen, Zhiwei, Luo, Qingquan, Cheng, Xinghua, Yu, Yongfeng, Niu, Xiaomin, Qian, Liqiang, Chen, Xiaoke, Gu, Linping, Liu, Ruijun, Ma, Shenglin, Huang, Jia, Chen, Tianxiang, Li, Ziming, Ji, Wenxiang, Song, Liwei, Shen, Lan, Jiang, Long, Yu, Zicheng, Zhang, Chao, Tai, Zaixian, Wang, Changxi, Chen, Rongrong, Carbone, David P, Xia, Xuefeng, Lu, Shun
Published in Journal of hematology and oncology (18.05.2022)
Published in Journal of hematology and oncology (18.05.2022)
Get full text
Journal Article